Peroutka, Stephen J.
Pharmaceutical Product Development, LLC.,
United States
2025 Rank: 15498
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1221 out of 360881 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 15498 | 18569 |
| Total Cites | 8226 | 8445 |
| H-index | 50 | 51 |
| Hm-index | 32 | 32 |
| Number of Single Authored Papers | 67 | 67 |
| Total Cites to Single Authored Papers | 2022 | 2042 |
| Number of Single+First Authored Papers | 119 | 119 |
| Total Cites to Single+First Authored Papers | 4247 | 4308 |
| Number of Single+First+Last Authored Papers | 189 | 189 |
| Total Cites to Single+First+Last Authored Papers | 6738 | 6852 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 6734 | 6842 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.23 |
| Self-Citation Percentage |
2.59%
|
|
Peroutka, Stephen J.
Stanford Healthcare,
United States
2024 Rank: 14405
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1171 out of 341636 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 14405 | 17239 |
| Total Cites | 8066 | 8283 |
| H-index | 49 | 50 |
| Hm-index | 32 | 32 |
| Number of Single Authored Papers | 63 | 63 |
| Total Cites to Single Authored Papers | 1976 | 1995 |
| Number of Single+First Authored Papers | 115 | 115 |
| Total Cites to Single+First Authored Papers | 4165 | 4225 |
| Number of Single+First+Last Authored Papers | 185 | 185 |
| Total Cites to Single+First+Last Authored Papers | 6601 | 6714 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 6588 | 6694 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.24 |
| Self-Citation Percentage |
2.62%
|
|
Peroutka, Stephen J.
Stanford Healthcare,
United States
2023 Rank: 13153
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1080 out of 323273 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 13153 | 15867 |
| Total Cites | 7922 | 8128 |
| H-index | 49 | 50 |
| Hm-index | 32 | 32 |
| Number of Single Authored Papers | 63 | 63 |
| Total Cites to Single Authored Papers | 1930 | 1947 |
| Number of Single+First Authored Papers | 114 | 114 |
| Total Cites to Single+First Authored Papers | 4082 | 4134 |
| Number of Single+First+Last Authored Papers | 185 | 185 |
| Total Cites to Single+First+Last Authored Papers | 6481 | 6575 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 6380 | 6472 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.26 |
| Self-Citation Percentage |
2.53%
|
|
Peroutka, Stephen J.
PRA International,
United States
2022 Rank: 11992
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1003 out of 305851 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 11992 | 14279 |
| Total Cites | 7694 | 7895 |
| H-index | 48 | 50 |
| Hm-index | 32 | 32 |
| Number of Single Authored Papers | 63 | 63 |
| Total Cites to Single Authored Papers | 1857 | 1874 |
| Number of Single+First Authored Papers | 114 | 114 |
| Total Cites to Single+First Authored Papers | 3963 | 4015 |
| Number of Single+First+Last Authored Papers | 185 | 185 |
| Total Cites to Single+First+Last Authored Papers | 6290 | 6384 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 6179 | 6271 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.26 |
| Self-Citation Percentage |
2.55%
|
|
Peroutka, Stephen J.
PRA International,
United States
2021 Rank: 11370
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 961 out of 278898 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 11370 | 13532 |
| Total Cites | 7522 | 7731 |
| H-index | 48 | 50 |
| Hm-index | 32 | 32 |
| Number of Single Authored Papers | 63 | 63 |
| Total Cites to Single Authored Papers | 1820 | 1837 |
| Number of Single+First Authored Papers | 114 | 114 |
| Total Cites to Single+First Authored Papers | 3866 | 3918 |
| Number of Single+First+Last Authored Papers | 185 | 185 |
| Total Cites to Single+First+Last Authored Papers | 6147 | 6241 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 6036 | 6129 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.26 |
| Self-Citation Percentage |
2.70%
|
|
Peroutka, Stephen J.
Stanford University Medical Center,
United States
2020 Rank: 11778
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Genetics & Heredity
Rank in SubField 1: 1046 out of 227881 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 11778 | 14347 |
| Total Cites | 7047 | 7227 |
| H-index | 46 | 47 |
| Hm-index | 30 | 30 |
| Number of Single Authored Papers | 47 | 47 |
| Total Cites to Single Authored Papers | 1589 | 1602 |
| Number of Single+First Authored Papers | 96 | 96 |
| Total Cites to Single+First Authored Papers | 3480 | 3518 |
| Number of Single+First+Last Authored Papers | 167 | 167 |
| Total Cites to Single+First+Last Authored Papers | 5692 | 5763 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 5657 | 5746 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.26 |
| Self-Citation Percentage |
2.49%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.